The effect of levofloxacin concentration on the development and maintenance of antibiotic-resistant clones of Escherichia coli in chemostat culture

Journal of Industrial Microbiology and Biotechnology

Volumn 29, Issue 4, 2002, Pages 155-162

  Fleming, G T ^a   McCarthy, D M ^a   Colombet, N ^b   Patching, J W ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^b Lycée Agricole et Viticole de Blanquefort   (France)

Author keywords

Chemostat; Competition; Escherichia coli; Levofloxacin resistance; Minimum selection concentration; Selection

Indexed keywords

AMPICILLIN; CHLORAMPHENICOL; COLISTIN; KANAMYCIN; LEVOFLOXACIN; NALIDIXIC ACID; NITROFURAN DERIVATIVE; STREPTOMYCIN; TETRACYCLINE; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; OFLOXACIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIUM CULTURE; BACTERIUM ISOLATE; BATCH FERMENTATION; CHEMOSTAT; CONTINUOUS FERMENTATION; DRUG TOLERANCE; ESCHERICHIA COLI; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PROTEIN BINDING; CHEMISTRY; CLASSIFICATION; CULTURE MEDIUM; DRUG EFFECT; GENETIC SELECTION; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MICROBIOLOGICAL EXAMINATION; MULTIDRUG RESISTANCE;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; NEGIBACTERIA;

ANTI-INFECTIVE AGENTS; BACTERIAL PROTEINS; CULTURE MEDIA; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; MICROBIAL SENSITIVITY TESTS; OFLOXACIN; SELECTION (GENETICS);

EID: 0036800739     PISSN: 13675435     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jim.7000295     Document Type: Article

References (36)

1. Biedenbach DJ and RN Jones. 1996. The comparative antimicrobial activity of levofloxacin tested against 350 clinical isolates of streptococci. Diagn Microbiol Infect Dis 25: 47-51.
2. Carrier MJ, ME Nugent, WCA Tacon and SB Primrose. 1984. High expression of cloned genes in Escherichia coli and its consequences. Trends Biotechnol 1: 109-113.
3. Caulcott CA. 1984. Competition between plasmid-positive and plasmid-negative cells. Biochem Soc Trans 12: 1140-1142.
4. Chopra I, K Hacker, Z Misulovin and DM Rothstien. 1990. Sensitive biological detection method for tetracyclines using a tetA-lacZ fusion system. Antimicrob Agents Chemother 34: 111-116.
5. Cohen SP, LM McMurry, DC Hooper, JS Wolfson and SB Levy. 1989. Cross-resistance to fluoroquinolones in multiple-antibiotic resistant (Mar) Escherichia coli by tetracycline or chloramphenicol: Decreased drug accumulation associated with membrane changes in addition to PmpF reduction. J Bacteriol 178: 306-308.
6. Del Mar Tavío M, J Vila, J Ruiz, AM Martín-Sánchez and MT Jiménz de Anta. 1999. Mechanisms involved in the development of resistance to fluoroquinolones in Escherichia coli isolates. J Antimicrob Chemother 44: 735-742.
7. Dougherty TJ, D Beaulieu and JF Barrett. 2001. New quinolones and the impact on resistance. Drugs Discov Today 6: 529-536.
8. Dykhuizen DE and DL Hartl. 1981. Selection in chemostats. Microbiol Rev 47: 150-168.
9. Enberg J, FM Aaerestrup, DE Taylor, P Gerner-Smidt and I Nachamkins. 2001. Quinolone and macrolide resistance in Campylobacter jejuni and C. coli: Resistance mechanisms and trends in human isolates. Emerg Infect Dis 7: 24-34.
10. Eng RH, FT Padberg, SM Smith, EN Tan and CE Cherubin. 1991. Bactericidal effects of antibiotics on slowly growing and non-growing bacteria. Antimicrob Agents Chemother 35: 1824-1828.
11. Erden BF, G Ulak, F Yildiz, T Yildiz, T Yikan, S Ozdemirici and N Garzar. 2001. Antidepressant, anixogenic, and antinociceptive properties of levofloxacin in rats and mice. Pharmacol Biochem Behav 68: 441-453.
12. Fleming G, MT Dawson and JW Patching. 1988. The isolation of strains of Bacillus subtilis showing improved plasmid stability characteristics by means of selective chemostat culture. J Gen Microbiol 134: 150-168.
13. Goldberg I and Z Er-El. 1981. The chemostat - An efficient technique for medium optimisation. Process Biochem 16: 2-8.
14. Heinemann JA, RG Ankenbauer and CF Amábile-Cuevals. 2000. Do antibiotics maintain antibiotic resistance? Drugs Discov Today 5: 195-204.
15. Helling RB, T Kinney and J Adams. 1981. The maintenance of plasmid-containing organisms in populations of Escherichia coli. J Gen Microbiol 123: 129-141.
16. Hooper DC. 2001. Emerging mechanisms of fluoroquinolone resistance. Emerg Infect Dis 7: 337-341.
17. Johnson AP, M Warner and DM Livermore. 2001. Activity of moxifloxacin and other quinolones against pneumococci resistant to first-line agents, or with high levels of ciprofloxacin resistance. Int J Antimicrob Agents 17: 337-381.
18. Jones RN and MA Pfaller. 2001. Can antimicrobial susceptibility testing results for ciprofloxacin or levofloxacin predict susceptibility to a newer fluoroquinolone gratiofloxacin? Report from the SENTRY antimicrobial surveillance program (1997-1999). Diagn Microbiol Infect Dis 39: 237-243.
19. Jones RN, MAT Croco, KC Kugler, MA Pfaller, ML Beach and The SENTRY Participants Group (North America and Canada, 1997). 2000. Respiratory tract pathogens isolated from patients hospitalised with suspected pneumonia: frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance (United States and Canada, 1997). Diagn Microbiol Infect Dis 37: 115-125.
20. Jones ME, NM Boenink, J Verhoef, K Kohrer and FJ Schmitz. 2000. Multiple mutations conferring ciprofloxacin resistance in Staphylococcus aureus demonstrates long-term stability in an antibiotic-free environment. J Antimicrob Chemother. 45: 353-356.
21. Klimberg IW, CE Cox, CL Fowler, W King, SS Kim and S Callery-D'Amico. 1998. A controlled trial of levofloxacin and lomefloxacin in the treatment of complicated urinary tract infection. Urology 51: 610-615.
22. Laemmli UK. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 259: 680-685.
23. Lebek G and R Egger. 1983. R-selection of sub-bacteriostatic tetracycline-concentrations. Zbl Bakt Hyg I Abr Orig A 255: 255-345.
24. Maniatis T. 1982. Appendix A: Biochemical techniques: Liquid media. In: Maniatis T, EF Fritsch and S Sambrook (Eds), Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory, USA, p. 440.
25. Martínez-Martínez L, A Pascual and GA Jacoby. 1998. Quinolone resistance from a transferable plasmid. Lancet 351: 797-799.
26. Naber KG. 2001. Which fluoroquinolones are suitable for the treatment of urinary tract infections? Int J Antimicrob Agents 17: 331-341.
27. National Committee for Clinical Laboratory Standards. 1997. Methods for Dilution Antimicrobial Susceptibility Tests for bacteria that grow aerobically, Vol. 17, No. 21, 4th Edn. Approved Standard, M7-A4, Wayne, PA, USA.
28. O'Reilly A and P Smith. 1999. Development of methods for predicting the minimum concentrations of oxytetracycline capable of exerting a selection for resistance to this agent. Aquaculture 180: 1-11.
29. Pavlasova E, E Stejskalova and B Sikyta. 1987. Stability of hyperproduction of D-serine deaminase and tryptophanase in Escherichia coli. Biotechnol Lett 9: 761-764.
30. +) in non-selective media. Biotechnol Bioeng 32: 740-773.
31. Segatore B, D Setacci, M Perilli, N Franceschini, F Marchetti and G Amiocosante. 2000. Bactericidal activity of levofloxacin and ciprofloxacin on clinical isolates of different phenotypes of Pseudomonas aeruginosa. Int J Chemother 13: 223-226.
32. Smith P. 1998. Towards the establishment of a breakpoint concentration for the determination of resistance to oxolinic acid in marine microflora. Aquaculture 166: 229-239.
33. Smith P, M Kane, S Dempsey, M Concannon, M McDonagh, R O'Kennedy, J Patching, K Callanan and L Pursell. 1996. Theoretical and practical implications of minimum effect concentration measurements of antimicrobial agents. In: Haagsma N and A Ruiter (Eds), Proceedings of the Euroresidue 111. Conference on Residues of Veterinary Drugs in Food. NVVL, The Netherlands, pp. 863-867.
34. Une T, T Fujimoto, K Sato and Y Osada. 1998. An optically active ofloxacin. J Antimicrob Chemother 32: 1336-1340.
35. Zelder O and B Hauer. 2000. Environmentally directed mutations and their impact on industrial biotransformation and fermentation processes. Curr Opin Microbiol 3: 248-251.
36. Zhou J, Y Dong, X Zhao, S Lee, A Amin, S Ramaswamy, J Domagala, JM Musser and K Drlica. 2000. Selection of antibiotic-resistant bacterial mutants: allelic diversity among fluoroquinolone-resistant mutations. J Infect Dis 182: 517-525.